ARCHIVES

NCI Places Hold On Genentech Drug Trials, Citing Disagreement Over Intellectual Property Provisions.

This article is from The Cancer Letter archive.

Vol. 36 No. 09 | March 12, 2010

Download PDF Visit The Full Archive

Related Articles

HHS News: Shalala Appoints Group On Genetic Testing

June 25, 1999

DCT Board Approves Concepts Of Eight New Biological Response Modifiers Program

July 3, 1981

RFA On Breast Cancer Low Fat Diet Available

November 25, 1983

Drug Combination Can Block Proteins Preventing Cell Death In Acute Lymphoblastic Leukemia

September 27, 2013

Vanderbilt, Jonsson Centers Win NCI SPORE Grants.

May 18, 2001

Study: Delaying ADT Until Symptoms Appear Can Be Safe in Men with a PSA-based Relapse

May 30, 2014